BioInformant

Your Global Leader in Stem Cell Market Research

Home » Stem Cells » MSCs » Page 3

Mesenchymal Stem Cells (MSCs)

Mesenchymal stem cells (MSCs) are a well-characterized population of adult stem cells that can differentiate into a variety of cell types (chondrocytes, osteoblasts, adipocytes, myocytes, and more).

AASCP To Host Free Virtual Congress and FDA Safety Panel on November 7-8, 2020

By Leave a Comment

On November 7-8, 2020, the American Academy of Stem Cell Physicians (AASCP) is hosting a Free Scientific Congress and Safety Panel with FDA participation.

Stem cells applications are expanding at an accelerating rate, with a search of the world’s largest clinical trial database (ClinicalTrials.gov) revealing that at least 7,994 trials now involve stem cell products or their derivatives. As the world’s largest database of clinical trials, this figure likely contains approximately three-quarters of clinical trials worldwide ― making the total count even higher.

In addition to stem cell products, a growing market has evolved for a diverse range of regenerative medicine products, including cellular therapies, immunotherapies, exosome therapies, biomaterials, tissue engineered products (TEPs), biologics, and more. [Read more…]

Do Stem Cell Treatments For Arthritis Work? Get the Facts.

By 1 Comment

Can stem cell treatment for arthritis bring relief to those suffering from the disease?

From the dawn of history to present day, the swelling and aching of joints rank as one of the most troublesome indicators of age. As connective tissue breaks down over time, the result is stiffening, pain and immobility. While some are luckier than others, few seem to escape it entirely – which is why stem cell treatment for arthritis is appealing to so many. [Read more…]

What are Placental Stem Cells and What are They Used For?

By Leave a Comment

What are placental stem cells and what are placental stem cells used for? As placental stem cells get explored for a variety of therapeutic applications, these questions become increasingly important. The opportunity to collect placental stem cells is also a once in a lifetime opportunity. [Read more…]

Diversifying Cord Blood Banking through Adipose-Derived Stem Cell Storage

By 1 Comment

The global cord blood banking industry has been rapidly maturing in recent years. In part, this has been caused by changes in processing, storage, and transplantation technologies. These changes require executives and industry decision-makers to have a firm understanding of emerging trends.

One of the most notable cord blood industry trends has been a diversification of services. Put simply, cord blood banks are becoming diversified stem cell biobanks. [Read more…]

Cynata Receives Ethics Approval to Commence Clinical Trial in COVID-19 and Clinical Development Update

By Leave a Comment

MELBOURNE, Australia, May 08, 2020 — Cynata Therapeutics Limited (ASX: “CYP”, “Cynata”, or the “Company”), a clinical-stage biotechnology company specialising in cell therapeutics, is pleased to announce that it has received ethics committee approval to commence a clinical trial to investigate early efficacy of Cynata’s proprietary Cymerus™ mesenchymal stem cells (MSCs) in adults admitted to intensive care with COVID-19. In addition, the Company also provides updated guidance on its wider clinical development pipeline. [Read more…]

BioInformant's World-Class Clients